Veru to participate in the 2025 btig virtual biotech conference

Miami, fl, july 22, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the company will be participating in one-on-one meetings and a fireside chat presentation with investors at the 2025 btig virtual biotech conference taking place from july 29-30, 2025.
VERU Ratings Summary
VERU Quant Ranking